These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunotherapy of metastasis. Dallal RM; Lotze MT Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596 [TBL] [Abstract][Full Text] [Related]
6. Novel vaccines and adjuvants for allergen-specific immunotherapy. Crameri R; Rhyner C Curr Opin Immunol; 2006 Dec; 18(6):761-8. PubMed ID: 17010585 [TBL] [Abstract][Full Text] [Related]
7. [Immunomodulation therapy for allergic asthma. What is already possible, what is to come?]. Taube C; Buhl R Dtsch Med Wochenschr; 2008 Apr; 133(14):727-32. PubMed ID: 18363195 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapeutic approaches for renal cancer. Pizza G; de Vinci C; Viza D Folia Biol (Praha); 2002; 48(5):167-81. PubMed ID: 12448765 [No Abstract] [Full Text] [Related]
18. Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune system. Rhee Fv Clin Cancer Res; 2007 Mar; 13(5):1353-5. PubMed ID: 17332275 [No Abstract] [Full Text] [Related]
19. Adjuvants for specific immunotherapy past, present, future. Drachenberg KJ Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1999; (93):275-9; discussion 280-1. PubMed ID: 11487886 [No Abstract] [Full Text] [Related]
20. Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer. Seya T; Akazawa T; Uehori J; Matsumoto M; Azuma I; Toyoshima K Anticancer Res; 2003; 23(6a):4369-76. PubMed ID: 14666723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]